CorMedix M&A Deal with Heron Therapeutics, Inc.
CorMedix Inc. announced a definitive agreement to acquire substantially all of the assets of Heron Therapeutics, Inc., including both commercial and pipeline assets. The acquisition is intended to provide scale and diversification to CorMedix's institutional care growth strategy and remains subject to Heron stockholder approval and regulatory clearance.
- Counterparty
- Heron Therapeutics, Inc.